Evidence map›Paper›PMID 36276654›Full record

ArticleTheranostics2022

CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy.

Tashbib Khan, Nicholas J Lyons, Madeline Gough, Kayden K X Kwah, Tahleesa J Cuda, Cameron E Snell, Brian W Tse, Kamil A Sokolowski, Lesley A Pearce, Timothy E Adams and 7 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Integrative Computational Framework,bioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Tashbib KhanMater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
Nicholas J LyonsMater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
Madeline GoughMater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
Kayden K X KwahMater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
Tahleesa J CudaMater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
Cameron E SnellMater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
Brian W TsePreclinical Imaging Facility, Translational Research Institute, Woolloongabba, QLD, Australia.
Kamil A SokolowskiPreclinical Imaging Facility, Translational Research Institute, Woolloongabba, QLD, Australia.
Lesley A PearceCommonwealth Scientific and Industrial Research Organisation Manufacturing, Parkville, VIC, Australia.
Timothy E AdamsCommonwealth Scientific and Industrial Research Organisation Manufacturing, Parkville, VIC, Australia.
Stephen E RoseCommonwealth Scientific and Industrial Research Organisation, Herston, QLD, Australia.
Simon PuttickCommonwealth Scientific and Industrial Research Organisation, Herston, QLD, Australia.
Marina PajicThe Kinghorn Cancer Centre, Garvan Institute of Medical Research, Faculty of Medicine, St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
Mark N AdamsSchool of Biomedical Sciences, Centre for Genomics and Personalised Health, Queensland University of Technology, Brisbane, QLD, Australia.
Yaowu HeMater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
John D HooperMater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
Thomas KryzaMater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
Commonwealth Scientific and Industrial Research Organisation · AUMater Health Services · AUQueensland University of Technology · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsColorectal NeoplasmsImmunoconjugatesAnimalsAntigens, NeoplasmCell Adhesion MoleculesCell Line, TumorCytotoxinsFemaleHumansMaleMiceRNA, MessengerXenograft Model Antitumor AssaysZirconiumAntigens, NeoplasmAntineoplastic AgentsCDCP1 protein, humanCell Adhesion MoleculesCytotoxinsImmunoconjugatesRNA, MessengerZirconiumantibody-drug conjugatecancerCDCP1receptortheranostics

Identifiers

PMID36276654
PMCPMC9576610
OpenAlexW4307230178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.